INSULIN OMISSION IN WOMEN WITH IDDM

被引:198
作者
POLONSKY, WH
APONTE, JE
ANDERSON, BJ
JACOBSON, AM
LOHRER, PA
COLE, CF
机构
[1] JOSLIN DIABET CTR, BOSTON, MA 02215 USA
[2] HARVARD UNIV, SCH MED, BOSTON, MA USA
关键词
D O I
10.2337/diacare.17.10.1178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- To describe the extent of intentional insulin omission in an outpatient population of women with insulin-dependent diabetes mellitus (IDDM) and examine its relationship to disordered eating, attitudes toward diabetes, other psychosocial factors, long-term complications, and glycemic control. RESEARCH DESIGN AND METHODS- Before their routinely scheduled clinic appointments, female IDDM patients who were 13-60 years of age completed a self-report survey (final n = 341). The survey included standardized questionnaires assessing disordered eating altitudes and behaviors, psychological functioning (general distress, diabetes-specific distress, and hypoglycemic fear), attitudes toward diabetes, and self-care behaviors. All subjects were assessed for glycosylated hemoglobin within 30 days of survey completion. Long-term complications were determined through chart review. RESULTS- Approximately 31% of the subject sample, representing women of all ages, reported intentional insulin omission, but only 8.8% reported frequent omission. Compared with non-emitters, emitters reported more disordered eating, greater psychological distress (general and diabetes-specific), more hypoglycemic fear, poorer regimen adherence, and greater fears concerning improved diabetes management (which may lead to weight gain). Omitters evidenced poorer glycemic control, more diabetes-related hospitalizations, and higher rates of retinopathy and neuropathy. Multivariate examination revealed only two variables that independently predicted omission: diabetes-specific distress and fear of improved glycemic control (''because I will gain weight''). Of the omitters, approximately half reported omitting insulin for weight-management purposes (weight-related omitters). These subjects evidenced significantly greater psychological distress, poorer regimen adherence (including more frequent omission), poorer glycemic control, and higher rates of complications than did non-weight-related emitters as well as non-emitters. Non-weight-related emitters tended to fall between weight-related omitters and non-emitters on most measures of psychological functioning, adherence, and CONCLUSIONS- These findings suggest that insulin omission is common, that it is not limited to younger women, and that the medical consequences of omission, especially frequent omission, may be severe. Although a strong association between omission and disordered eating was observed, these data suggest that this link may be complicated by important diabetes-specific factors. Patients preoccupied with eating and weight concerns may also become emotionally overwhelmed by diabetes and/or fearful of normoglycemia (and the associated weight related consequences), thus reinforcing the desire to omit insulin and maintain elevated blood glucose levels.
引用
收藏
页码:1178 / 1185
页数:8
相关论文
共 25 条
[1]  
BIRK R, 1987, DIABETES S1, V36, pA88
[2]  
BRINK JS, 1987, PEDIATRIC ADOLESCENT, P273
[3]  
CHASE HP, 1989, PRACT DIABETOLOGY, V8, P20
[4]   EATING DISORDERS AND RETINAL LESIONS IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC WOMEN [J].
COLAS, C ;
MATHIEU, P ;
TCHOBROUTSKY, G .
DIABETOLOGIA, 1991, 34 (04) :288-288
[5]   FEAR OF HYPOGLYCEMIA - QUANTIFICATION, VALIDATION, AND UTILIZATION [J].
COX, DJ ;
IRVINE, A ;
GONDERFREDERICK, L ;
NOWACEK, G ;
BUTTERFIELD, J .
DIABETES CARE, 1987, 10 (05) :617-621
[6]   THE BRIEF SYMPTOM INVENTORY - AN INTRODUCTORY REPORT [J].
DEROGATIS, LR ;
MELISARATOS, N .
PSYCHOLOGICAL MEDICINE, 1983, 13 (03) :595-605
[7]   EATING DISORDERS IN YOUNG-ADULTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS - A CONTROLLED-STUDY [J].
FAIRBURN, CG ;
PEVELER, RC ;
DAVIES, B ;
MANN, JI ;
MAYOU, RA .
BRITISH MEDICAL JOURNAL, 1991, 303 (6793) :17-20
[8]  
Greco P, 1990, DIABETES, V40, pA165
[9]  
HAYES EJ, 1981, CLIN CHEM, V27, P476
[10]  
LAGRECA AM, 1987, DIABETES CARE, V10, P659